Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution ...Middle East

PR Newswire - News
EINDHOVEN, Netherlands, Nov. 3, 2020 /PRNewswire/ -- Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable...

Read More Details
Finally We wish PressBee provided you with enough information of ( Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution )

Apple Storegoogle play

Also on site :



Latest News